Skip to main content

Table 2 Comparison of peripheral immune cells among GCA, TAK, and HCs

From: Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis

Immune cell subtype (cells per μL)

GCA, n = 12

TAK, n = 8

HC for GCA, n = 5

HC for TAK, n = 5

ANOVA

Post hoc test

p value

GCA vs TAK

GCA vs HC

TAK vs HC

CD4+ T

491 ± 207

621 ± 282

512 ± 203

383 ± 231

0.36

   

 CD4 HLA-DR+

16 ± 8.9

11 ± 3.2

8.5 ± 0.80

7.6 ± 5.1

0.074

   

 CD4 naive

214 ± 38

248 ± 47

270 ± 66

210 ± 59

0.85

   

 CD4 Teff

5.1 ± 4.5

26 ± 53

5.4 ± 3.2

18 ± 21

0.46

   

 CD4 Tcm

194 ± 96

220 ± 90

143 ± 33

121 ± 71

0.18

   

 CD4 Tem

78 ± 49

128 ± 83

66 ± 1.0

77 ± 29

0.18

   

 Th1

80 ± 42

114 ± 18

62 ± 6.1

62 ± 30

0.23

   

 Th1 HLA-DR+

25 ± 14

18 ± 19

9.3 ± 3.1

13 ± 11

0.22

   

 Th2

40 ± 20

28 ± 18

20 ± 9.7

19 ± 18

0.10

   

 Th2 HLA-DR+

6.4 ± 1.6

3.0 ± 2.2

2.1 ± 1.0

3.1 ± 1.9

0.13

   

 Th17

57 ± 38

78 ± 33

36 ± 14

31 ± 14

0.061

   

 Th17 HLA-DR+

9.9 ± 8.5

10 ± 5.0

4.0 ± 1.9

5.1 ± 4.1

0.26

   

 Treg

20 ± 12

25 ± 16

11 ± 5.9

12 ± 5.3

0.16

   

 Treg HLA-DR+

8.9 ± 7.2

7.8 ± 4.2

5.0 ± 1.0

3.1 ± 1.5

0.20

   

 Tfh

68 ± 29

87 ± 31

63 ± 20

36 ± 21

0.025

0.43

0.98

0.014

 Tfh1

16 ± 8.8

25 ± 3.3

15 ± 0.9

11 ± 4.9

0.063

   

 Tfh2

8.3 ± 5.0

9.1 ± 8.8

4.1 ± 1.1

5.2 ± 3.6

0.41

   

 Tfh17

24 ± 11

29 ± 9.8

23 ± 10

10 ± 7.6

0.035

0.21

0.99

0.057

 Tfr

5.1 ± 2.5

5.6 ± 3.5

3.7 ± 0.14

2.6 ± 2.6

0.23

   

CD8+ T

189 ± 115

331 ± 128

228 ± 126

163 ± 52

0.039

0.044

0.93

0.033

 CD8 HLA-DR+

24 ± 22

16 ± 9.6

5.6 ± 2.6

6.6 ± 4.1

0.12

   

 CD8 naive

23 ± 17

77 ± 50

94 ± 61

74 ± 19

0.015

0.054

0.043

0.99

 CD8 Teff

90 ± 89

98 ± 52

30 ± 12

43 ± 23

0.24

   

 CD8 Tcm

20 ± 13

28 ± 21

9.9 ± 4.6

12 ± 6.6

0.15

   

 CD8 Tem

57 ± 35

128 ± 87

54 ± 23

51 ± 15

0.024

0.028

0.99

0.033

γδT

5.5 ± 5.1

22 ± 26

4.7 ± 1.7

18 ± 32

0.22

   

NKT

29 ± 33

43 ± 34

3.7 ± 0.7

29 ± 13

0.22

   

CD19+ B

97 ± 51

211 ± 175

226 ± 89

94 ± 42

0.045

0.11

0.17

0.23

 CD27− IgD+ naive B

79 ± 48

161 ± 151

186 ± 77

52 ± 13

0.052

   

 CD27− IgD+ activated B

2.4 ± 1.6

6.7 ± 5.3

13 ± 4.8

13 ± 11

0.0038

0.35

0.017

0.29

 CD27+ IgD− memory B

11 ± 5.8

31 ± 20

18 ± 3.9

16 ± 12

0.015

0.0086

0.74

0.17

 Plasmablast

0.6 ± 0.8

3.3 ± 5.3

0.2 ± 0.06

0.9 ± 1.0

0.17

   

 Plasma cell

0.5 ± 0.5

2.1 ± 3.4

0.05 ± 0.0

0.3 ± 0.4

0.17

   

NK

171 ± 170

149 ± 77

123 ± 6.4

153 ± 48

0.92

   

DC

14 ± 9.7

17 ± 14

21 ± 3.7

19 ± 15

0.72

   

 mDC

8.2 ± 5.8

6.6 ± 2.3

15 ± 1.4

11 ± 5.4

0.035

0.88

0.071

0.43

 pDC

1.3 ± 1.0

2.2 ± 1.4

3.2 ± 1.7

4.5 ± 6.4

0.20

   

Monocyte

209 ± 91

258 ± 30

93 ± 43

158 ± 38

0.024

0.59

0.11

0.020

 CD14++ CD16−

144 ± 73

188 ± 94

80 ± 4.3

116 ± 35

0.096

   

 CD14++ CD16+

48 ± 36

44 ± 22

5.3 ± 0.5

20 ± 15

0.040

0.98

0.049

0.30

 CD14+ CD16+

11 ± 7.0

16 ± 7.3

4.5 ± 3.5

12 ± 3.1

0.084

   

Eosinophil

76 ± 36

135 ± 115

50 ± 40

63 ± 45

0.14

   

Neutrophil

4009 ± 2054

4329 ± 2425

1232 ± 688

1551 ± 759

0.013

0.98

0.073

0.036

Basophil

30 ± 25

35 ± 14

30 ± 0.1

26 ± 26

0.90

   
  1. Comparison between of baseline peripheral immune cell number between GCA (n = 12), TAK (n = 8), HC for GCA (n = 5), and HC for TAK (n = 5) using ANOVA and post hoc test
  2. Th helper T, Tfh follicular helper T, NK natural killer, DC dendritic cell, mDC myeloid DC, pDC plasmacytoid DC